Cargando…

Roles of LINC01473 and CD74 in osteoblasts in multiple myeloma bone disease

The suppression of osteoblast (OB) activity is partially responsible for multiple myeloma (MM) bone disease. Long non-coding RNAs (lncRNAs) play a vital role in bone formation and resorption. However, their functions in OBs from patients with MM have rarely been reported. Through high-throughput seq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Fengping, Yan, Siyang, Liu, Hui, Liu, Zhaoyun, Jiang, Fengjuan, Cao, Panpan, Fu, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240337/ https://www.ncbi.nlm.nih.gov/pubmed/35145037 http://dx.doi.org/10.1136/jim-2021-002192

Ejemplares similares

CCN1 stimulated the osteoblasts via PTEN/AKT/GSK3β/cyclinD1 signal pathway in Myeloma Bone Disease
por: Yan, Siyang, et al.
Publicado: (2019)

Multiple myeloma-derived exosomes inhibit osteoblastic differentiation and improve IL-6 secretion of BMSCs from multiple myeloma
por: Liu, Zhaoyun, et al.
Publicado: (2020)

Relationship between abnormal osteoblasts and cellular immunity in multiple myeloma
por: Fu, Rong, et al.
Publicado: (2014)

P827: STUDY ON THE PERCENTAGE AND FUNCTION OF TSCM CELLS AND THE ANTITUMOR EFFECT IN VITRO AMPLIFICATION IN PATIENTS WITH MULTIPLE MYELOMA
por: Cao, Panpan, et al.
Publicado: (2023)

Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
por: Jiang, Fengjuan, et al.
Publicado: (2021)

Deficient invariant natural killer T cells had impaired regulation on osteoclastogenesis in myeloma bone disease
por: Jiang, Fengjuan, et al.
Publicado: (2018)

Pim-2 Kinase Regulates Energy Metabolism in Multiple Myeloma
por: Liu, Zhaoyun, et al.
Publicado: (2022)

Osteoblast suppression in multiple myeloma bone disease
por: Adamik, Juraj, et al.
Publicado: (2018)

Predictive Role of Immune Profiling for Survival of Multiple Myeloma Patients
por: Zhaoyun, Liu, et al.
Publicado: (2021)

Tumor‐associated macrophages regulate the function of cytotoxic T lymphocyte through PD‐1/PD‐L1 pathway in multiple myeloma
por: Zhang, Jiangbo, et al.
Publicado: (2022)

Immune checkpoint inhibitors for multiple myeloma immunotherapy
por: Liu, Zhaoyun, et al.
Publicado: (2023)

An overview of pim kinase as a target in multiple myeloma
por: Liu, Zhaoyun, et al.
Publicado: (2023)

Myeloma Bone Disease: The Osteoblast in the Spotlight
por: Andrews, Rebecca E., et al.
Publicado: (2021)

Epigenetic‐Based Mechanisms of Osteoblast Suppression in Multiple Myeloma Bone Disease
por: Adamik, Juraj, et al.
Publicado: (2019)

The Metabolic Features of Osteoblasts: Implications for Multiple Myeloma (MM) Bone Disease
por: Lungu, Oxana, et al.
Publicado: (2023)

PB2136: THE VALUE OF PERIPHERAL BLOOD LYMPHOCYTE SUBSETS IN PREDICTING THE PROGNOSIS OF NEWLY DIAGNOSED MULTIPLE MYELOMA
por: Liu, Zhaoyun, et al.
Publicado: (2023)

Osteoblast inhibition by chemokine cytokine ligand3 in myeloma-induced bone disease
por: Fu, Rong, et al.
Publicado: (2014)

Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001
por: Abrahams, Cristina L., et al.
Publicado: (2018)

Therapeutic strategies to enhance immune response induced by multiple myeloma cells
por: Liu, Zhaoyun, et al.
Publicado: (2023)

P811: PIM2 KINASE REGULATES TIGIT EXPRESSION AND ENERGY METABOLISM IN NK CELLS OF PATIENTS WITH MULTIPLE MYELOMA
por: Liu, Zhaoyun, et al.
Publicado: (2023)

Involvement of MM cell-derived exosomes in T lymphocytes immune responses
por: Shao, Qing, et al.
Publicado: (2020)

The Exosomes Containing LINC00461 Originated from Multiple Myeloma Inhibit the Osteoblast Differentiation of Bone Mesenchymal Stem Cells via Sponging miR-324-3p
por: Wu, Yang, et al.
Publicado: (2022)

Adiponectin inhibits the differentiation and maturation of osteoclasts via the mTOR pathway in multiple myeloma
por: Liu, Zhaoyun, et al.
Publicado: (2020)

Retracted: The Exosomes Containing LINC00461 Originated from Multiple Myeloma Inhibit the Osteoblast Differentiation of Bone Mesenchymal Stem Cells via Sponging miR-324-3p
por: Engineering, Journal of Healthcare
Publicado: (2023)

Molecular Features of the Mesenchymal and Osteoblastic Cells in Multiple Myeloma
por: Iannozzi, Nicolas Thomas, et al.
Publicado: (2022)

Study on the Effect of EZH2 Inhibitor Combined with TIGIT Monoclonal Antibody against Multiple Myeloma Cells
por: Liu, Zhaoyun, et al.
Publicado: (2023)

Study on Tim3 Regulation of Multiple Myeloma Cell Proliferation via NF-κB Signal Pathways
por: Liu, Zhaoyun, et al.
Publicado: (2020)

Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts
por: Faict, Sylvia, et al.
Publicado: (2018)

The short-term effect of histone deacetylase inhibitors, chidamide and valproic acid, on the NF-κB pathway in multiple myeloma cells
por: Liu, Zhaoyun, et al.
Publicado: (2019)

Human Myeloma Cell Lines Induce Osteoblast Downregulation of CD99 Which Is Involved in Osteoblast Formation and Activity
por: Oranger, Angela, et al.
Publicado: (2015)

CD74 in Kidney Disease
por: Valiño-Rivas, Lara, et al.
Publicado: (2015)

lncRNA MSTRG.29039.1 Promotes Proliferation by Sponging hsa-miR-12119 via JAK2/STAT3 Pathway in Multiple Myeloma
por: Liu, Zhaoyun, et al.
Publicado: (2021)

Clinical features and treatment outcome of elderly multiple myeloma patients with impaired renal function
por: Chen, Jin, et al.
Publicado: (2019)

First-line treatment with bortezomib rapidly stimulates both osteoblast activity and bone matrix deposition in patients with multiple myeloma, and stimulates osteoblast proliferation and differentiation in vitro
por: Lund, Thomas, et al.
Publicado: (2010)

P710: MONOCYTES MEDIATE NK CELL FUNCTION EXHAUSTION IN MDS PATIENTS VIA CD200/CD200R PATHWAY
por: Guo, Yixuan, et al.
Publicado: (2023)

Bone marrow mesenchymal stem cells regulate the dysfunction of NK cells via the T cell immunoglobulin and ITIM domain in patients with myelodysplastic syndromes
por: Liu, Zhaoyun, et al.
Publicado: (2022)

Autoantibodies in Spondyloarthritis, Focusing on Anti-CD74 Antibodies
por: Liu, Yuan, et al.
Publicado: (2019)

The role of CD74 in cardiovascular disease
por: Li, Qiu-Lin, et al.
Publicado: (2023)

RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells
por: Huang, Beihui, et al.
Publicado: (2023)

CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas
por: Xu, Shengchao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r60n6t26tl69v0l4o5ld4cg93s